1-Chloro-1,3-dihydro-3,3-dimethyl-1,2-benziodioxole, 95.0%, 5g

1-N-Fmoc-2-Cyanopiperidine, 95.0%, 1g

1-(4-Methoxybenzyl)-3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 98%, 1g

Polvere di zinco, minimo 98%, <63 µm, stabilizzata, 2,5 kg, confezione in vetro

4-((6-Aminohexyl)oxy)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione 2,2,2-trifluoroacetate, 98%, 100mg

3-Bromo-5-hydroxybenzoic Acid>98.0%(GC)(T)5g

5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine, 95.0%, 5g

Methyl 6-(aminomethyl)picolinate hydrochloride, 95.0%, 5g

4-isocyanatocyclopentene, 95.0%, 500mg

Ethyl-5-(aminomethyl)-2-furoate hydrochloride, 95.0%, 5g

2-Bromo-5-fluoro-N-methylbenzamide, 95.0%, 25g

GRAPIPRANT, 95%, 5mg

(E)-4-(3-Hydroxyprop-1-en-1-yl)-2,6-dimethoxyphenol, 98%, 250mg